Vimarsana
Biggest News Aggregation in the World

Page 3 - Dan Ferry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dan Ferry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dan Ferry Today - Breaking & Trending Today

Medicenna Therapeutics Corp. (NASDAQ:MDNA) Q3 2023 Earnings Call Transcript - Vimarsana News

Medicenna Therapeutics Corp. (NASDAQ:MDNA) Q3 2023 Earnings Call Transcript

Operator: Hello and welcome to the Medicenna Therapeutics Fiscal Third Quarter Earnings Call. All participants are now in a listen-only mode.

Rain Therapeutics Inc. (NASDAQ:RAIN) Q3 2022 Earnings Call Transcript - Vimarsana News

Rain Therapeutics Inc. (NASDAQ:RAIN) Q3 2022 Earnings Call Transcript

Operator: Greetings, and welcome to the Rain Therapeutics Third Quarter Earnings Conference Call. At this time all participants are in a listen-only mode.

Rain Therapeutics Inc. (RAIN) Q3 2022 Earnings Call Transcript - Vimarsana News

Rain Therapeutics Inc. (RAIN) Q3 2022 Earnings Call Transcript

Rain Therapeutics Inc. (NASDAQ:NASDAQ:RAIN) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants Dan Ferry – LifeSci Advisors Avanish Vellanki – Chief...

Medicenna Extends Period to Exercise Certain Warrants - Vimarsana News

Medicenna Extends Period to Exercise Certain Warrants

30.09.2022 - TORONTO and HOUSTON, Sept. 30, 2022 (GLOBE NEWSWIRE) - Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immunotherapy company, today announced that it has received conditional approval from the ...

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q1 2023 Results - Earnings Call Transcript - Vimarsana News

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q1 2023 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (NASDAQ:NASDAQ:MDNA) Q1 2023 Earnings Conference Call August 15, 2022, 08:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Fahar Merchant -...